Residency programs often provide residents with the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare MUE, research, and CQI projects, describing the implementation approach and publishability difference. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB.
Angela Slampak-Cindric, PharmD, BCPS, BCCCP, (she/her) received her PharmD from the University of Pittsburgh. She is a critical care pharmacist and director of the PGY2 Critical Care Pharmacy Residency at Geisinger Medical Center. She is a board-certified critical care pharmacist, pharmacotherapy specialist, and an active member of both ASHP and the Society of Critical Care Medicine. She is passionate about critical care, teaching, and fostering the development of healthcare professionals.
Bryan Hayes, PharmD, DABAT, FAACT, FASHP, (he/him) is an emergency medicine pharmacist and clinical toxicologist at Massachusetts General Hospital and assistant professor of emergency medicine (EM) at Harvard Medical School. He serves as the program director of the PGY2 EM residency and is a clinical pharmacy manager of EM, pediatric, and overnight services.
Christopher Schriever, PharmD, MS, AAHIVP, (he/him) earned a bachelor's degree at the University of Iowa followed by a master's degree in Biological Science with an emphasis in molecular biology from Northern Illinois University. He earned his PharmD at the UIC College of Pharmacy, followed by a PGY1 residency at Jesse Brown VA and a two-year fellowship in Infectious Diseases at the UIC College of Pharmacy. He is currently a clinical associate professor at UIC College of Pharmacy, Rockford.